Oxalic Acid

Oxalic Acid

SCHEMBL7019455

CC(N)c1ccoc1.O=C(O)C(=O)O

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 1/20 0.33
ALOX5 P09917 7/20 0.53
TRPA1 O75762 1/20 0.39
CYP3A4 P08684 1/20 0.38
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
HCAR2 Q8TDS4 1/20 0.35
SLC6A3 Q01959 1/20 0.33
ADRB2 P07550 1/20 0.33
ROCK2 O75116 1/20 0.32
ROCK1 Q13464 1/20 0.32
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL7019451 1.00 ALOX5 (0.53) ALOX5TRPA1CYP3A4SLC1A3SLC1A2
SCHEMBL142208 0.88
SCHEMBL1219534 0.76 ALOX5 (0.51) ALOX5TRPA1CYP3A4PTGS1PTGS2
SCHEMBL25660312 0.76 ALOX5 (0.47) ALOX5SLC1A3SLC1A2SLC1A1HCAR2
Oxalic Acid SCHEMBL28194607 0.73 LMNA (0.52) ALOX5ADRB2
SCHEMBL5158897 0.72 ALOX5 (0.47) ALOX5TRPA1CYP3A4SLC1A3SLC1A2
SCHEMBL8882558 0.72 ALOX5 (0.44) ALOX5CYP3A4SLC1A3SLC1A2SLC1A1
SCHEMBL5929608 0.72 ALOX5 (0.47) ALOX5TRPA1CYP3A4SLC1A3SLC1A2
SCHEMBL3867319 0.72 ALOX5 (0.44) ALOX5TRPA1CYP3A4SLC1A3SLC1A2
SCHEMBL19494055 0.71 SRC (0.50) ALOX5TRPA1CYP3A4SLC1A3SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed